MorningSignal
Research Platform
2026-09-28 13:40
type: earnings-brief session: AM date: 2026-07-28 daily_note: "[[Daily/2026-07-28]]" tags: [earnings, sellside]
← [[Daily/2026-07-28|Back to the daily note]]
This catch-up run preserves the missed America/Toronto business date 2026-07-28. Market-reaction references use the latest completed U.S. session on or before the target date: the 2026-07-28 regular-session close. The deterministic collector identified 49 same-day BMO candidates above $2 billion and 25 unresolved prior-evening AMC names. Its discovery fields were useful, but several “actual revenue” fields were stale and disagreed with issuer releases; all decision-grade figures below therefore come from issuer releases, filings, and complete transcripts where explicitly identified.
The highest-information result is [[GLW]]. Corning delivered a real operating beat—Optical sales +32%, enterprise +65%, core operating margin 20.9%, and $1.42 billion of free cash flow—but the stock fell 13.3% because the $4.9–$5.0 billion Q3 sales guide and $0.85–$0.89 core-EPS guide did not clear the valuation-implied AI acceleration hurdle. Full Q&A shows no demand break: LTAs will underpin the “lion’s share” of future optical capacity, enterprise growth remains a major Q3 driver, and management says capacity—not demand—is binding. The security is now less expensive, but approximately 36x annualized Q3 EPS still requires flawless scale-up. Action: WAIT; begin work only below $110 or after Q4 guidance proves sequential acceleration.
[[BA]] crossed a genuine operating milestone: 171 deliveries, $631 million of quarterly free cash flow, debt down $1.3 billion sequentially, and record $715 billion backlog. However, core EPS missed the collector’s dated consensus and Defense remained loss-making because of a $280 million VC-25B charge. This partially confirms the TIF watchlist catalyst, but not the price condition. Action: WAIT ≤$200; no chase at $222.63.
[[UPS]] raised FY26 revenue, adjusted operating profit, and EPS guidance, yet fell 6.7%. The release supports an operating inflection after the Amazon glide-down, but the quality of the mix is unresolved: U.S. Domestic revenue per piece rose 9.3% while adjusted margin was only 8.0%, and International revenue per piece rose 18.9% while operating profit declined. Action: HOLD / no new money above $100 until volume, price/mix, and network savings are reconciled in full Q&A.
[[SHW]], [[RCL]], [[IQV]], and [[TRU]] delivered the cleanest release-only beats. Sherwin gained share in weak coatings markets and raised adjusted EPS; Royal Caribbean beat on close-in demand and raised FY EPS; IQVIA’s 1.22x book-to-bill and 7.5% next-12-month backlog conversion support a CRO recovery; TransUnion’s 10% organic constant-currency growth and raised guide show credit-data demand broadening. The stocks’ 5%–14% gains absorb much of the FY1 improvement. Actions: SHW HOLD / wait ≤$325; RCL HOLD / wait ≤$285; IQV HOLD / wait ≤$220; TRU HOLD / wait ≤$78.
[[CARR]] is the key negative divergence. Orders were exceptional—commercial HVAC +65% and data centers +300%—but adjusted operating margin fell 190 basis points on mix and input costs, and the stock fell 9%. The FY guide rose, yet the print proves backlog is not the same as earnings conversion. Action: WAIT; require margin stabilization or a price below $58.
No open Analytical Ledger entry matched these reporters. Boeing’s human-authored TIF company note remains the relevant prior threshold; it is preserved unchanged. No Ledger row was silently replaced or closed.
| Ticker | Report verified | Prior TIF state | Market cap | 7/28 close move | Transcript status | Tier | Reason |
|---|---|---|---|---|---|---|---|
| GLW | Issuer release + current/prior full Q&A | No Ledger row | $123.4B | -13.3% | Current and prior full transcript; complete Q&A | TIER 1 — FULL UNDERWRITE | Large AI-optical read-through and >5% move |
| BA | Issuer release; delivery release | T3 watchlist company note; no Ledger row | $166.7B | +5.3% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | TIF watchlist and FCF catalyst |
| UPS | Issuer release | No Ledger row | $96.0B | -6.7% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | Freight-demand read-through and >5% move |
| RCL | Issuer release | No Ledger row | $81.8B | +4.8% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | Consumer-demand read-through; near 5% move |
| SHW | Issuer release | No Ledger row | $80.7B | +8.5% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | Coatings/housing read-through and >5% move |
| CARR | Issuer release | No Ledger row | $57.9B | -8.9% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | AI cooling/orders conversion and >5% move |
| IQV | Issuer/Business Wire release | No Ledger row | $35.6B | +14.0% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | CRO demand inflection and >5% move |
| TRU | Issuer release/presentation | No Ledger row | $14.9B | +8.5% | Full current/prior Q&A not verified | TIER 1 — FULL UNDERWRITE | Credit-data demand and >5% move |
| KO, SPGI, GSK, BCS, ITW, AMT, ECL, HLT, PCAR, PYPL, FMX, CNC, DTE, CNP, XYL, HUBB, PHG, CMS, DINO, IVZ | Calendar/result evidence; source depth incomplete | No matching Ledger row | >$13B | mixed | Collector flags are not transcript proof | TIER 3 — DEFERRED | Lower priority than completed Tier 1 slate; exact gates below |
| INCY, TXT | Result detected; material move | No matching Ledger row | >$16B | +10.9% / -5.7% | Complete primary package and prior Q&A not verified | TIER 3 — DEFERRED | Move triggered escalation, but primary-source/expectations gate failed |
| PNR, OSK, ALKS, RGEN, AXTA, AWI, PJT, CVLT, HRI, RITM, KNSA, FELE, PII, ABG, ITRI, CURB, AB, CBU, JBLU | Actual-result evidence not validated by cutoff | No matching Ledger row | >$2B | mixed/unknown | Not verified | TIER 3 — DEFERRED | Current issuer release and transcript absent from validated evidence set |
PM decision line — FINAL — POST CALL. The market expected a Q2 beat plus a forward acceleration sufficient to justify the stock’s AI-optical multiple. Corning beat the quarter, but Q3 guidance implied roughly similar year-over-year growth rather than the step-up embedded in positioning; the stock closed at $124.22, down 13.3% from $143.36. The call shows the business trajectory is intact and capacity-constrained, but the security still prices a demanding slope. Action: WAIT; medium confidence; initiate only below $110 or after Q4 guidance confirms sequential acceleration and optical margin expansion.
Pre-print expectations stack. Prior management guidance was approximately $4.6 billion of Q2 core sales and $0.73–$0.77 core EPS. The collector’s dated consensus snapshot was $0.76 EPS; Investing.com reported $4.62 billion sales and $0.75 EPS. A credible buy-side hurdle was not verifiable. At the prior $143.36 close, annualizing the Q3 core-EPS midpoint of $0.87 implied roughly 41x earnings: the valuation required optical/AI acceleration, not merely a beat. No prior TIF Ledger threshold existed.
| Metric | Prior guide | Dated consensus | Actual | Variance / rate of change | Classification |
|---|---|---|---|---|---|
| Core sales | ~$4.6B | $4.62B | $4.738B | +2.6% vs consensus; +9% QoQ; +17% YoY | STRUCTURAL POSITIVE |
| Core EPS | $0.73–$0.77 | $0.75–$0.76 | $0.78 | +4%; +11% QoQ; +30% YoY | STRUCTURAL POSITIVE |
| Core operating margin | n/a | not verifiable | 20.9% | +190 bps YoY; +70 bps QoQ | STRUCTURAL POSITIVE |
| Optical sales | n/a | not verifiable | $2.07B | +32% YoY; enterprise +65% | STRUCTURAL POSITIVE |
| Solar profit | Q2 includes $30M shutdown cost | not verifiable | $(7)M | loss after planned shutdown; Q3 improvement guided | TIMING NEGATIVE |
| Q3 sales / EPS | n/a | hurdle not verifiable | $4.9–$5.0B / $0.85–$0.89 | ~16% / ~28% YoY, but below valuation-implied acceleration | EXPECTATIONS NEGATIVE |
Release-only read preserved. The quarter said the operating engine was stronger than the price reaction implied: enterprise AI orders accelerated, Optical net income grew 77%, and gross/operating margins expanded. Three questions required the call: (1) did Q3 guidance signal enterprise deceleration; (2) are LTAs financially binding enough to protect returns on the $2 billion capex program; and (3) is carrier’s 1% growth a demand break or project timing?
Operating engine. First, Optical sales of $2.07 billion grew 32%, while net income grew 77% to $438 million; profit grew more than twice as fast as revenue because higher-value fiber/cable/connectivity products captured customer deployment savings. Second, enterprise sales grew 65% to $1.27 billion and GenAI product sales nearly doubled, while scale-up and photonics contributed little: current growth is scale-out demand, leaving optionality if optical ports and in-box photonics rise. Third, carrier grew only 1% in Q2, but first-half carrier sales grew about 17%; project timing, not cancellation evidence, supports a timing classification. Fourth, Solar sales grew 90% to $438 million but lost $7 million after the planned $30 million maintenance hit. Q3 profit improvement is the reversal test. The compound positive is enterprise volume plus value-based mix plus LTA-backed capacity. The compound risk is high capex plus an unquantified photonics adoption slope. The buried signal is that LTAs are expected to become the “lion’s share” of Optical: customer-backed capacity can convert an AI capex boom from speculative supply build into contract-supported return on capital.
Call forensics and sentiment. Provenance: complete Investing.com current transcript accessed 2026-07-28; full Q&A ends with the operator disconnect. Prior comparison: complete MarketBeat Q1 2026 transcript dated 2026-04-28. Management continuity: Wendell Weeks and Ed Schlesinger in both calls.
Prepared remarks moved from Q1’s promise to “upgrade again” after two additional hyperscaler LTAs to Q2’s quantified $20B/$30B/$40B annualized sales plan and 19% 2026–2030 CAGR. The second language delta is risk-sharing: Q1 said customer agreements would share expansion risk; Q2 said all significant capacity moves are backed by LTAs and those agreements should become most of Optical. The third delta is Solar: Q1 warned the wafer ramp was behind plan and embedded $30 million of Q2 cost; Q2 reported the shutdown complete and guided profit improvement in Q3. Management delivered the disclosed cost/timing, improving credibility on that commitment.
| Analyst pressure point | Executive answer | Grade | Model implication |
|---|---|---|---|
| Asiya Merchant, Citi: why limited Q4 growth after Q3? | Schlesinger/Weeks said Q3 may hit the $20B run-rate a quarter early and no Q4 deceleration message was intended | B | No cut to demand; Q4 remains unquantified |
| Josh Pechter, UBS: has photonics/scale-up changed? | Weeks said ecosystem trade-offs remain, timing is hard, and no specific 2027 photonics number was guided | B- | Preserve long-term option; do not put $1B into FY27 base |
| George Notter, Wolfe: LTA mix and pricing? | Weeks said LTAs will be the lion’s share; value pricing, not bare-fiber inflation, drives margin | A- | Raises durability of capacity returns and Optical margin |
| Wamsi Mohan, BofA: Q3 deceleration and weak incremental margin? | Schlesinger denied deceleration, named handheld/auto offsets, but did not quantify each bridge | B | Hold Q3 midpoint; no upside until mix bridge is disclosed |
| Joseph Cardoso, JPMorgan: Q3 margin step-up? | Schlesinger tied it to Solar recovery and continued Optical scale | B+ | Q3 margin should improve; Solar is the observable test |
| Meta Marshall, Morgan Stanley: carrier weakness? | Weeks quantified first-half carrier growth near 17% and called Q2 project timing | A- | Classify carrier Q2 as timing pending Q3 |
Prepared confidence was high; Q&A confidence narrowed modestly when analysts demanded a 2027 photonics slope and Q4 precision. CEO/CFO framing was aligned. Tone score +75; QoQ delta 0 (STABLE); answer quality 62/100; prepared-to-Q&A pressure delta -25. Explicit omissions: no dollar value or take-or-pay floor for current LTAs, and no FY27 photonics revenue guide. Credibility is IMPROVED on Solar delivery and UNCHANGED on long-range AI timing. Company and Electronic Components tracker updates were written and read back through the deterministic renderer.
Release-to-call delta. Release-only conclusion: strong business, expectations miss. The call strengthened it by proving LTA-backed capacity and quantifying carrier first-half growth. It weakened it by refusing to quantify the photonics adoption curve or Q4. Judgment changed: no—WAIT remains. Remaining unmodelable variable: FY27 photonics revenue and customer capital contribution, expected no earlier than the next quarterly update.
Debate ledger.
| Live claim | Evidence threshold | Evidence received | Verdict | Next resolution |
|---|---|---|---|---|
| Consensus: AI optical growth must accelerate | Q3/Q4 enterprise and Optical growth above Q2 slope | Q3 guide implies similar YoY growth | WEAKENED near term | Q4 guide |
| Credible bull: demand exceeds Corning capacity | Orders accelerate; customer-backed expansion | “If we could make more, we could sell more”; LTAs back capacity | STRENGTHENED | Capex/LTA disclosure |
| Credible bear: photonics timing is slipping | FY27 number removed or delayed | No FY27 number ever formally guided; timing remains uncertain | UNRESOLVED | First explicit FY27 guide |
| Valuation-implied market: >40x requires flawless execution | Beat plus material guide raise | Beat, no slope raise | FALSIFIED for the old price | Q4 EPS/multiple |
FY1/FY2 bridge and valuation. FY1 moves up modestly because Q2 beat the top of guide and Q3 midpoint is $0.87. The algebra is enterprise volume × value-added connectivity mix × >20% Optical margin, partly offset by weaker handhelds and Solar start-up costs. FY2 is not responsibly point-estimable without photonics timing. A transparent range is more useful: at $3.60–$4.10 FY27 core EPS, 28x–35x yields $101–$144. The $124.22 close sits near the middle; a $110 entry is roughly 30x the low-mid range and restores asymmetry.
Thesis/narrative delta. Demand, mix, margin, competitive position, and LTA-backed capital allocation are REINFORCED. Catalyst timing is UNRESOLVED. Management credibility is IMPROVED on Solar and UNCHANGED on photonics. Entering the print, GLW was an AI-optical acceleration stock; after the release, it became a guide-disappointment stock; after Q&A, the durable story is capacity-constrained growth with uncertain slope; after the settled reaction, valuation is reset but not cheap. Business delta positive; estimate delta modestly positive; stock delta sharply negative and mostly multiple-driven.
Subsector and competitive prior. Optical-components economics are governed by a linked chain: hyperscaler capital budgets create cluster demand; network architecture determines fiber and connector content per accelerator; qualification and uptime requirements narrow the supplier set; glass/fiber draw capacity and cabling assembly constrain near-term supply; and the mix of passive connectivity versus photonic components sets margin and capital intensity. Corning is vertically advantaged because it controls glass science, fiber, cable, and engineered connectivity, while a hyperscaler can value faster deployment and lower labor more than the cost of bare fiber. That is the economic basis for value pricing and for the much faster growth in Optical profit than sales. It is also why the LTA terms matter: customer-backed expansion can protect utilization and returns, but an agreement without minimum volume, pricing protection, or capital contribution can still leave Corning holding cycle risk.
The near-term bear case is not that AI clusters need less bandwidth. It is that customer architectures, deployment schedules, and component mix can change before new capacity earns its target return. Scale-out connectivity is already shipping; scale-up and in-box photonics remain less quantified. If copper reaches farther than expected, co-packaged optics adoption slips, or customers redesign around fewer connectors, the content curve can disappoint even while total compute spending rises. Conversely, if rack density and cluster size keep increasing, Corning can monetize both more fiber and more engineered connectivity per deployment. The call supports the first-order demand case but leaves the second-order content and timing case open.
Estimate architecture and risk budget. A defensible model should separate enterprise scale-out, carrier, emerging photonics, Display, Solar, and other businesses rather than extrapolate consolidated growth. Enterprise has the highest current rate of change and the greatest valuation sensitivity; carrier supplies a slower cyclical recovery; Solar creates a visible Q3 margin reversal; Display and other segments can dampen consolidated volatility. The forecast should therefore assign no FY27 photonics revenue until a customer qualification or management target is disclosed, apply the Q3 midpoint to the near term, and give upside only when Optical margin and customer-backed capacity convert together. This treatment deliberately sacrifices some bull-case precision to avoid capitalizing an unannounced adoption curve.
At the portfolio level, the trigger is asymmetric evidence, not simply a lower share price. Below $110, the same operating facts would offer a better multiple cushion; above that level, the preferred confirmation is Q4 revenue and EPS acceleration with Optical margin holding above 21%. A broken thesis would require more than one quarter of lumpiness: enterprise order deceleration, a meaningful LTA cancellation, or capacity additions that depress cash conversion without incremental Optical profit would do it. Until one side resolves, the correct stance is a monitored wait rather than treating a 13% decline as automatic value.
Decision card. WAIT; medium confidence; 0% until trigger. Confirm with Q3 sales ≥$5.0B, core EPS ≥$0.89, Optical margin above Q2, and Solar profitable. Falsify with enterprise growth below 30%, Optical margin below 20%, or Q4 guide below the Q3 midpoint. Next catalyst: Q3 earnings, expected October 2026. Entry: ≤$110 or evidence-supported FY27 EPS above $4.10. Ten-second line: the AI-optical business is intact, but the old multiple required a guide raise that did not arrive.
PM decision line — PROVISIONAL — RELEASE ONLY. The pre-print debate was whether higher deliveries would finally produce positive free cash flow without another quality or defense charge. Boeing delivered $24.56 billion of revenue, 171 commercial aircraft, $631 million of free cash flow, and record $715 billion backlog, but core loss per share of $0.76 missed the collector’s dated $(0.34) consensus and Defense absorbed a $280 million VC-25B loss. The stock closed $222.63, +5.3%. Action: WAIT; preserve the TIF ≤$200 plus positive-FCF entry rule.
The prior TIF company note is a T3 watchlist: its thesis requires sustained 737 production at 47/month, positive quarterly free cash flow, and a better entry. Q2 satisfies only the cash-flow leg. A credible buy-side hurdle and revenue-consensus range were not verifiable. The release shows the security is still a turnaround underwrite, not a clean compounder.
| KPI | Actual | YoY / sequential evidence | Classification |
|---|---|---|---|
| Revenue | $24.56B | +8% YoY | STRUCTURAL POSITIVE |
| Commercial deliveries | 171 | +14% YoY; 314 H1 | STRUCTURAL POSITIVE |
| BCA margin | (2.7)% | +240 bps YoY | IMPROVING, NOT YET ECONOMIC |
| Free cash flow | $631M | vs $(200)M YoY | POSITIVE; working-capital quality pending |
| Debt | $45.9B | down from $47.2B Q1 | STRUCTURAL POSITIVE |
| BDS margin | (0.2)% | down from +1.7% | STRUCTURAL NEGATIVE |
| Backlog | $715B | record; 6,200+ aircraft | STRUCTURAL POSITIVE |
The operating engine is delivery volume × aircraft mix × BCA unit margin, plus Services annuity, less Defense fixed-price charges and interest. The 737 line began transitioning to 47/month and activated low-rate initial production on the North Line in July. Certification flight testing for the 737-7 and -10 is complete, with first deliveries still expected in 2027. The buried signal is not EPS—it is the combination of positive FCF and $1.3 billion sequential debt reduction. The compound negative is equally clear: BCA still loses money and BDS remains exposed to fixed-price charges. A single quarter of working-capital-favorable cash flow does not prove normalized $7–$9 billion FCF.
Release-only debate: the bull claim that delivery recovery is converting to cash is strengthened; the bear claim that quality/compliance and fixed-price programs cap normalized margins is unresolved; the prior TIF claim that $223 prices a clean recovery remains unchanged. FY1 improves because 171 deliveries and positive FCF pull forward cash conversion. FY2 still depends on sustaining 47/month, certifying both MAX variants, BCA margin crossing zero, and BDS charges falling. At the close, the stock is above the TIF price trigger and only one quarter into cash recovery.
Provisional thesis matrix: demand/backlog reinforced; production improved; margins improved but unresolved; balance sheet improved; Defense execution weakened; management credibility pending call. Business delta positive; estimate delta mixed because cash improves while core loss misses; stock delta positive and consistent with a milestone, but not enough to create entry asymmetry.
Subsector and competitive prior. Commercial-aircraft economics are set less by quarterly order intake than by certified production rate, delivery reliability, customer advances, supplier health, and the learning curve on each program. Boeing sits at the prime-contractor and systems-integration node: airlines and lessors provide the backlog, thousands of suppliers provide structures and systems, regulators control certification and production authorization, and Boeing captures the residual economics only after rework, concessions, abnormal costs, and program accounting. The duopoly and a multi-year installed backlog create strategic scarcity, but they do not immunize cash flow from execution. A delivered aircraft releases inventory and customer cash; an undelivered aircraft traps working capital and often adds rework cost.
That mechanism is why 171 deliveries and positive free cash flow deserve more weight than the accounting loss, but also why one quarter cannot be annualized. Cash can benefit from delivery timing, customer deposits, supplier payment timing, or inventory liquidation. Structural improvement requires unit cost and traveled work to fall while deliveries remain high. The observable chain is therefore production rate → first-pass quality → delivery flow → BCA margin → free cash flow → debt reduction. Q2 clears the delivery, cash, and debt links; it does not yet clear first-pass quality or positive BCA margin.
Program and balance-sheet bridge. The 737 family supplies the fastest path to earnings normalization because rate, mix, and inventory unwind can scale together. The 787 contributes attractive widebody cash economics, while 777X and the -7/-10 certifications retain timing and cash-risk optionality. Defense is economically separate: fixed-price development programs can generate charges even as Commercial improves, and the VC-25B charge proves that exposure is still live. Services is the stabilizer because the installed fleet generates parts, maintenance, and support demand with less new-program risk.
For FY1, the right bridge starts with deliveries and working-capital release, subtracts defense charges and interest, and avoids treating backlog as near-term revenue. For FY2, a sustainable 47-per-month 737 rate, zero-to-positive BCA margin, fewer defense charges, and lower interest from debt repayment must occur together. At $222.63, the market already capitalizes a substantial share of that path. The ≤$200 rule is not arbitrary: it creates room for one more execution setback while retaining the upside from normalized cash flow. The call must establish whether Q2 cash was repeatable before the milestone can be promoted into a durable earnings revision.
Three decisive call questions: Is 47/month sustainable for two quarters without traveled work or quality spillover? How much of Q2 FCF was delivery timing/advances versus structural unit economics? What remaining loss-at-completion exposure sits in VC-25B, KC-46, T-7A, and 777X?
Decision card. WAIT; medium-low confidence; no position. Confirm with another positive-FCF quarter, BCA margin above 0%, and debt below $45B. Falsify with FAA rate restriction, BDS charge above $2B, or 777X delay beyond 2027. Entry remains ≤$200 with positive FCF intact. Full current Q&A, prior-call language comparison, and management sentiment are PENDING — CALL, due 2026-07-29 08:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. Published adjusted EPS of $1.76 beat the collector’s dated $1.65 consensus, and UPS raised FY26 revenue to ~$91.2 billion, adjusted operating profit to ~$8.65 billion, and adjusted EPS to ~$7.22. The stock nevertheless closed $105.41, down 6.7%, because the mix behind the growth is not yet proven durable. Action: HOLD / no new money above $100; require volume and margin proof.
The reported quarter included $891 million after-tax transformation charges, or $1.05 per share, mainly employee separation costs. That bridge matters: GAAP EPS was $0.71 versus $1.76 adjusted. The adjustment is not the source of the adjusted beat versus consensus, but the 60% gap between adjusted and GAAP EPS makes cash conversion and recurring restructuring essential checks.
| KPI | Q2 2026 | YoY / guide implication | Classification |
|---|---|---|---|
| Consolidated revenue | $22.8B | growth; FY guide raised | STRUCTURAL POSITIVE |
| Adjusted EPS | $1.76 | above $1.65 dated consensus | POSITIVE |
| U.S. Domestic revenue / piece | +9.3% | revenue +6.0% | MIX/PRICE POSITIVE |
| U.S. Domestic adjusted margin | 8.0% | vs 7.0% prior-year adjusted | IMPROVING |
| International revenue / piece | +18.9% | revenue +12.5% | MIX/PRICE POSITIVE |
| International operating profit | $623M | down from $672M | STRUCTURAL QUESTION |
| Supply Chain Solutions margin | 10.2% | profit $291M vs $234M | STRUCTURAL POSITIVE |
The engine is package volume × revenue per piece − pickup/delivery/network cost. The Amazon glide-down and network reconfiguration reduce low-yield density before savings fully arrive, so reported revenue growth led by price/mix can coexist with investor concern about volume. U.S. Domestic adjusted profit improved despite nearly zero GAAP margin after transformation charges. International is the buried negative: 18.9% revenue-per-piece growth did not prevent operating profit from declining. That can reflect fuel, geography, weight, or temporary costs; without Q&A, it is not modelable. Supply Chain Solutions provides a positive offset through forwarding, logistics, and healthcare.
The release-only bull claim—network reconfiguration is now converting to adjusted earnings—is strengthened by the guide raise. The bear claim—revenue-per-piece is masking weak density or volume—is unresolved. The stock’s decline says the market demands a cleaner volume/margin bridge than the headline guide provides.
FY1 is anchored to the company’s $7.22 adjusted-EPS guide. At $105.41, the stock trades near 14.6x that guide. FY2 upside requires U.S. Domestic margin to compound from 8% as automation/network savings exceed wage and volume pressure. A 100-basis-point margin move on roughly $60 billion annualized Domestic revenue is about $600 million of operating profit, the key sensitivity. Downside is a volume contraction that erodes density faster than price/mix and savings can offset.
Provisional thesis matrix: network restructuring improved; price/mix reinforced; volume unresolved; International margin weakened; guidance improved; credibility pending call. Business delta modestly positive; estimate delta positive; stock delta negative, implying concern about earnings quality rather than FY1 level.
Subsector and competitive prior. Parcel-network economics depend on density: a route, facility, aircraft, and sort wave carry large fixed costs, so incremental packages are highly profitable when they fit the existing network and destructive when low-yield volume forces extra capacity. UPS competes on reach, reliability, time-definite service, customs capability, and enterprise integration, while shippers compare that service against FedEx, postal consolidators, regional carriers, and their own logistics. Revenue per piece is therefore only one side of the equation. The investment question is whether price and customer mix improve contribution per stop after accounting for route density, miles, handling touches, and labor.
The Amazon glide-down tests that model. Shedding low-yield volume can improve mix but initially removes packages from routes that still run, creating a volume hole before facilities, headcount, and sort capacity are removed. Network reconfiguration is successful only when avoided cost exceeds lost contribution and service does not deteriorate. That makes adjusted Domestic margin, average daily volume, pieces per stop, and realized headcount/facility savings the causal KPIs. A 9.3% increase in revenue per piece is encouraging, but without the volume and fuel/currency bridge it cannot establish that core price is doing the work.
Segment and estimate bridge. U.S. Domestic is the central profit pool and the largest source of FY2 operating leverage. International has cross-border mix and aircraft/network sensitivity; the combination of 18.9% revenue-per-piece growth and lower profit is a red flag because price/mix should normally produce leverage. Supply Chain Solutions is smaller but can add higher-value healthcare and logistics revenue without the same last-mile density constraint. The FY1 guide says management expects the combined transformation to work, yet the $891 million after-tax charge shows that the transition is economically real even if excluded from adjusted EPS.
The base case should use the $7.22 adjusted-EPS guide but discount any multiple expansion until cash restructuring costs fall and reported earnings converge toward adjusted earnings. FY2 upside comes from Domestic margin above 9%, stable or positive daily volume, and International profit resuming growth. Downside comes from another volume contraction that leaves fixed network cost stranded, or price increases that accelerate customer switching. At roughly 14.6x guidance the valuation is not extreme, but the earnings-quality discount is warranted. A price at or below $100, combined with a disclosed volume trough and quantified savings, would improve the reward-to-risk more than the guide raise alone.
Three decisive call questions: What were Domestic and International average daily volumes, and how much of revenue-per-piece came from fuel/currency/mix? How much of the $8.65 billion adjusted operating-profit guide comes from completed headcount/network savings versus demand? Why did International profit fall despite double-digit revenue and revenue-per-piece growth?
Decision card. HOLD / WAIT for ≤$100; medium confidence. Confirm with Domestic adjusted margin ≥9% and non-negative volume by Q3. Falsify with another quarter of International profit decline or FY26 operating-profit guide below $8.5B. Next catalyst: Q3 earnings, October 2026. Full current/prior Q&A and call sentiment remain PENDING — CALL, due 2026-07-29 08:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. Royal Caribbean beat its own Q2 expectations, reported adjusted EPS of $4.21 versus the collector’s $3.97 snapshot, and raised FY26 adjusted EPS to $17.73–$17.87. Close-in demand, lower costs, and joint ventures drove the beat. The stock closed $319.74, +4.8%; at roughly 18x the new midpoint, much of the improvement is recognized. Action: HOLD; new money below $285.
| KPI | Q2 / FY26 | Rate of change / implication | Classification |
|---|---|---|---|
| Revenue | $4.832B | +6% YoY | STRUCTURAL POSITIVE |
| Adjusted EPS | $4.21 | vs $4.38 prior year; above guide/consensus | MIXED BUT BETTER THAN FEARED |
| Capacity | +5% | 2.4M guests, +6% | STRUCTURAL POSITIVE |
| Load factor | 110.2% | ~flat YoY | STABLE |
| Net yields | +1.9%; +1.2% CC | exceeded guide on close-in demand | STRUCTURAL POSITIVE |
| NCC ex fuel / APCD | +4.4%; +3.9% CC | Q2 cost inflation; favorable timing aided beat | STRUCTURAL NEGATIVE / TIMING |
| FY adjusted EPS | $17.73–$17.87 | raised; ~14% YoY | STRUCTURAL POSITIVE |
The cruise engine is capacity × load factor × ticket/onboard yield − cost per APCD − fuel/interest. Capacity and guests grew, load factor remained full, and close-in demand lifted yield. However, Q2 net cruise cost per APCD excluding fuel rose 3.9% constant currency. Management says favorable expense timing helped the quarter and guides Q3 ex-fuel unit costs down 1.6%–1.1% constant currency. That reversal is the critical proof. A 1% yield change is worth $156 million for FY26, while a 1% change in ex-fuel cost is worth $73 million; yield has more than twice the earnings sensitivity.
The buried signal is geopolitical, not broad consumer weakness. FY guidance incorporates modest booking pressure on selected itineraries, while aggregate demand and pricing remain at records. The compound positive is capacity growth plus high load plus price; the compound risk is $4.7 billion of 2026 capex plus scheduled debt maturities and itinerary disruption.
The release-only debate favors the bull on consumer demand and the company on yield. The bear retains evidence on unit-cost inflation and capital intensity. FY1 rises to the $17.80 midpoint. FY2 depends on net yield staying positive as capacity grows 6%–7%, unit costs normalizing, and new ships/destinations earning above the cost of capital. At 18x FY1, upside requires another estimate raise; a 16x multiple on $17.80 is ~$285, the preferred entry.
Provisional thesis matrix: demand reinforced; pricing improved; occupancy unchanged; cost architecture unresolved; balance sheet/capex unchanged; catalyst timing improved. Business and estimate deltas are positive; stock delta is positive and broadly proportionate.
Subsector and competitive prior. Cruise economics combine hotel-style occupancy, airline-like capacity discipline, and destination/onboard monetization. Ships are fixed assets that must sail, so load factor above 100%—reflecting third and fourth passengers in cabins—creates powerful operating leverage. Ticket yield, onboard spending, itinerary mix, fuel, crew, port expense, and dry-dock timing determine profit per available passenger cruise day. Royal Caribbean’s differentiation is the scale and amenity density of its ships, private destinations, loyalty ecosystem, and itinerary portfolio; those assets can support price premiums but require years of committed capital.
The value chain runs from shipyards and financiers through the cruise operator to travel advisers and guests. New ships enter on fixed schedules and cannot be flexed like hotel rooms, so an operator must stimulate demand or accept lower yield if capacity outruns bookings. Conversely, record booked load and close-in pricing let incremental revenue fall through at high margins. This quarter’s stable 110.2% load factor alongside positive net yields indicates price rather than occupancy filled the incremental capacity. That is better quality than discount-led load, but the release does not quantify onboard versus ticket yield or the geographic mix.
Estimate and capital bridge. FY1 improves through higher close-in revenue, joint-venture contribution, and favorable expense timing. The timing component must reverse, which makes the guided Q3 decline in constant-currency unit cost a hard audit point. FY2 depends on new capacity achieving mature yields, private-destination spending increasing wallet share, and financing/fuel costs remaining contained. The $4.7 billion capex program should be assessed against incremental EBITDA and ROIC, not celebrated as capacity alone. A ship can grow reported revenue while diluting value if its cost, launch expense, or financing burden exceeds normalized cash returns.
The consumer risk is nonlinear. Cruise bookings are discretionary and exposed to airfare, recession, health events, and geopolitical itinerary changes, yet the product can gain share from land vacations when its bundled value remains attractive. Current evidence says selected itinerary pressure, not a broad consumer retrenchment. Falsification would be weaker close-in price across multiple geographies, rising cancellations, or load falling as capacity expands. At approximately 18x FY1, the stock needs continued estimate revisions and clean unit-cost conversion. A $285 entry equates to roughly 16x the new midpoint and supplies a buffer against one quarter of itinerary or cost noise.
Three decisive call questions: How much Q2 EPS outperformance was expense timing and joint ventures versus repeatable yield? Which itineraries/geographies account for geopolitical booking pressure? What FY27 ROIC is underwritten on the 2026 capex cohort?
Decision card. HOLD; wait ≤$285; medium confidence. Confirm with Q3 net yield at least flat, ex-fuel unit costs down ≥1%, and FY EPS ≥$17.73. Falsify with negative net yields, load factor below 108%, or FY EPS below $17.50. Full current/prior Q&A and call sentiment remain PENDING — CALL, due 2026-07-29 08:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. Sherwin grew sales 7.5%, same-store sales 4.2%, adjusted EPS 9.5%, and adjusted EBITDA margin 60 basis points while management said end-market demand did not meaningfully improve. The company raised FY adjusted EPS to $11.80–$12.20. The stock closed $355.18, +8.5%, or about 29.6x the guide midpoint. Action: HOLD; wait ≤$325.
| KPI | Actual | YoY / mechanism | Classification |
|---|---|---|---|
| Sales | $6.789B | +7.5% | STRUCTURAL POSITIVE |
| Paint Stores same-store sales | +4.2% | vs +0.8% prior year; price mid-single digit, volume low-single digit | STRUCTURAL POSITIVE |
| Adjusted EPS | $3.70 | +9.5%; above $3.56 snapshot | STRUCTURAL POSITIVE |
| Adjusted EBITDA margin | 21.5% | +60 bps | STRUCTURAL POSITIVE |
| Paint Stores margin | 24.6% | -20 bps | MIX/INPUT-COST NEGATIVE |
| Consumer Brands adjusted margin | 24.5% | +210 bps | MIX/ACQUISITION POSITIVE |
| FY adjusted EPS guide | $11.80–$12.20 | raised from $11.50–$11.90 | STRUCTURAL POSITIVE |
The coatings engine is store/customer volume × price/mix − raw materials − labor/store investment. Paint Stores sales rose 5.1%, with mid-single-digit price and low-single-digit volume; that is better quality than pure pricing. Protective/marine grew double digits, commercial high single digits, and residential repaint mid-single digits. Yet Paint Stores margin slipped 20 basis points because raw-material and growth investments absorbed the gain. Consumer Brands’ 21.5% sales growth includes Suvinil acquisition contribution and FX; its margin gain cannot be treated as pure organic leverage. Performance Coatings improved sales 6.3% and adjusted margin 50 basis points.
The EPS-quality gate passes provisionally: the $0.27 gap between GAAP $3.43 and adjusted $3.70 is acquisition amortization and restructuring. These are disclosed, but recurring Valspar amortization should not be capitalized as operating surprise. The beat is operating-led—sales, share, and EBITDA—not tax or buyback alone.
The buried signal is that the company took share in weak demand rather than benefiting from a housing recovery. That makes the gain more durable but also means macro upside is optional rather than in the current run rate. The debate turns on price-cost: management implemented pricing against raw-material inflation, but the Paint Stores margin has not yet expanded.
FY1 is anchored at $12.00 adjusted EPS. At 29.6x, the close prices a high-quality share gainer and some demand recovery. FY2 upside requires 3%–5% same-store sales with 50–100 bps of consolidated margin expansion. At 27x the FY1 midpoint, value is ~$324; at 30x, ~$360. The reaction moved the stock to the top of this near-term range.
Provisional thesis matrix: demand/volume improved; pricing reinforced; margin mixed; competitive position improved; guidance improved; credibility pending call. Business and estimate deltas are positive; stock delta is positive and largely complete.
Subsector and competitive prior. Architectural coatings are a local service-and-distribution business wrapped around chemical formulation. Paint quality matters, but contractor access, tinting consistency, store proximity, color systems, technical support, and product availability create the moat. Sherwin-Williams is vertically integrated from formulation and manufacturing through a dense company-owned store network, allowing it to capture price, control merchandising, and serve professional painters quickly. Raw-material suppliers—resins, pigments, solvents, packaging—sit upstream; contractors, homeowners, industrial finishers, and protective/marine customers sit downstream. Demand is linked to repaint activity, housing turnover, construction, industrial production, and maintenance cycles.
The Paint Stores segment deserves the highest weight because professional repaint is repeat-purchase, labor-sensitive, and less discretionary than new construction. Mid-single-digit price plus low-single-digit volume in weak markets indicates share gain and pricing power, but the 20-basis-point margin decline says raw-material and investment costs have not fully cleared. Consumer Brands is harder to read because Suvinil and currency expand reported growth; Performance Coatings provides diversified industrial exposure. The quality hierarchy is therefore organic gallon growth, price realization, gross margin, segment margin, and cash conversion—not consolidated sales alone.
Price-cost and estimate bridge. Coatings margins respond with a lag. Raw-material inflation appears first in input cost; pricing reaches customers later; temporary spread compression then reverses if demand holds. Management’s price action raises the probability of recovery, but the evidence arrives only when Paint Stores margin expands without volume contraction. FY1 uses the $12.00 midpoint and includes acquisition and restructuring adjustments that should be separated from organic execution. FY2 can outperform if low-single-digit gallons combine with realized price and 50–100 basis points of margin recovery. It can disappoint if pricing suppresses demand or if titanium dioxide, resins, and packaging remain inflationary.
Competitive share gain in a flat market is valuable because it creates a larger installed contractor relationship base ahead of any housing recovery. It also raises the expectation hurdle: at nearly 30x FY1, the market already assumes high-quality compounding and some normalization. A $325 entry at roughly 27x preserves a premium for the franchise without paying fully for cyclical upside. The call needs to distinguish company-specific gallons from acquisition and price, quantify the remaining raw-material gap, and show that Consumer Brands margin improvement is not merely purchase-accounting or mix. Until then, the operating beat is real but the post-print security is fairly valued.
Three decisive call questions: How much of Paint Stores comp was price versus gallon volume by end market? When does pricing fully recover raw-material inflation? How much Suvinil acquisition contribution is embedded in FY sales/EPS guide?
Decision card. HOLD; wait ≤$325; medium confidence. Confirm with Paint Stores volume positive and segment margin ≥25% in Q3. Falsify with negative volume, gross-margin contraction, or FY adjusted EPS below $11.80. Full current/prior Q&A and sentiment remain PENDING — CALL, due 2026-07-29 08:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. Carrier raised FY sales, adjusted operating profit, and EPS after orders rose about 40%, commercial HVAC 65%, and data-center orders more than 300%. Yet adjusted operating margin fell 190 basis points and the stock closed $63.13, down 8.9%. Action: WAIT; require margin stabilization or ≤$58.
| KPI | Actual | Rate of change / mechanism | Classification |
|---|---|---|---|
| Sales / organic sales | $6.351B / +3% | returned to growth | STRUCTURAL POSITIVE |
| Adjusted EPS | $0.86 | -7% YoY; above $0.83 snapshot | MIXED |
| Adjusted operating margin | 17.2% | -190 bps | STRUCTURAL NEGATIVE |
| Commercial HVAC orders | +65% | data centers >+300% | STRUCTURAL POSITIVE |
| CSA sales / margin | +4% / 24.4% | margin -260 bps | MIX/INPUT-COST NEGATIVE |
| FCF | $810M | vs $568M | STRUCTURAL POSITIVE |
| FY adjusted EPS | ~$2.90 | raised from ~$2.80 | POSITIVE, PARTLY BELOW-LINE/MIX |
The engine is equipment volume × price/mix + aftermarket/service − input cost and factory/launch burden. Orders and backlog provide demand visibility, but the P&L shows unfavorable mix: CSA commercial sales fell 8% on customer-delivery timing while lower-margin residential/light-commercial grew. CSAME margin fell 350 basis points, partly because lower JV income reflected Middle East conflict. Transportation margin fell 160 basis points as high-growth containers replaced truck/trailer. These are causally related mix effects, not four independent misses.
The buried signal is the gap between order growth and margin conversion. Data-center backlog can be strategically valuable, but if early shipments carry installation/launch costs or low equipment margins, the equity value arrives only when service attach and factory utilization improve. Full-year EPS rises just $0.10 despite order growth above 40%; that is the expectations gap behind the selloff.
FY1 is ~$2.90 adjusted EPS; the close is ~21.8x. FY2 upside requires record backlog converting with adjusted margin back above 18.5% and aftermarket growth. A 100-basis-point margin recovery on ~$23 billion sales is ~$230 million of operating profit, roughly $0.20–$0.25 per share after tax. If margin remains 17%, the data-center narrative does not translate.
Provisional thesis matrix: demand/backlog improved; residential volume improved; pricing/mix weakened; margin weakened; FCF improved; guide improved; credibility pending call. Business delta positive on demand but negative on conversion; estimate delta modestly positive; stock delta negative and rational until margin is explained.
Subsector and competitive prior. HVAC economics span equipment design, compressors and components, channel inventory, installation, controls, and decades of aftermarket service. Residential equipment is more price- and replacement-cycle sensitive; commercial systems are specification-driven and can attach controls and service; transport refrigeration has its own fleet and freight cycles. Carrier’s strategic advantage comes from an installed base, engineering qualification, distribution, and the ability to bundle equipment, controls, and lifecycle service. Data centers add a demanding thermal-management use case, but customer orders can carry customized engineering, factory-ramp, commissioning, and mix costs before the service annuity develops.
Orders are a leading indicator, not earnings. The causal chain is qualified project → firm order → backlog → scheduled delivery → equipment gross margin → commissioning → service attach → cash. Q2 strongly validates the order and backlog links, particularly commercial HVAC and data centers. It weakens the delivery-to-margin link because commercial timing shifted mix toward residential/light commercial, and because Transportation’s container growth carried lower margin than truck/trailer. Middle East joint-venture income adds a geopolitical, below-segment-operating variable. Management must decompose these effects so investors can distinguish temporary mix from a structurally lower margin on growth products.
Estimate architecture. FY1 EPS around $2.90 incorporates the raised guide, but only a $0.10 increase despite approximately 40% order growth. That gap implies either conservatism, delayed conversion, or weak incremental economics. FY2 deserves upside only if backlog converts at an adjusted margin above 18.5%, data-center equipment attaches service, and free cash flow remains strong through working-capital growth. A 100-basis-point consolidated margin recovery could add roughly $0.20–$0.25 per share, but the reverse sensitivity is equally important if high-growth mix remains dilutive.
The $58 entry threshold corresponds to about 20x FY1 EPS, a more defensible price for a business still proving post-portfolio-transformation margins. The bull case is that data-center thermal intensity and commercial replacement create multi-year demand, factory utilization improves, and aftermarket compounds. The bear case is that competitors price aggressively, hyperscalers pressure equipment economics, and service attach arrives later than capex. The release settles demand but not value capture. The next call must quantify backlog margin, commercial delivery timing, price/cost, and service content before the order surge can be converted into a higher normalized earnings base.
Three decisive call questions: What share of data-center backlog is equipment versus service and what is the margin curve? When do Q2 commercial delivery timing effects reverse? How much of FY EPS lift is price/cost, mix, share count, and divestiture?
Decision card. WAIT; medium confidence. Confirm with organic sales ≥3%, adjusted margin ≥18.5%, and data-center backlog conversion without FCF dilution. Falsify with margin below 17%, order growth below 15%, or FY EPS below $2.80. Entry ≤$58 or post-call evidence of margin normalization. Full current/prior Q&A and sentiment remain PENDING — CALL, due 2026-07-29 08:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. IQVIA reported $4.368 billion revenue, $994 million adjusted EBITDA, $3.15 adjusted EPS, $3.15 billion net new bookings, and 1.22x book-to-bill; all exceeded the company’s expectations, and FY guidance rose. The stock closed $243.08, +14.0%. Action: HOLD; wait ≤$220 because the operating inflection is now substantially priced.
| KPI | Q2 | YoY / forward implication | Classification |
|---|---|---|---|
| Revenue | $4.368B | +8.7% | STRUCTURAL POSITIVE |
| R&D Solutions revenue | $2.575B | +8.8%; +6.7% ex reimbursed | STRUCTURAL POSITIVE |
| Net new bookings / book-to-bill | $3.15B / 1.22x | +19% bookings | STRUCTURAL POSITIVE |
| Backlog / NTM conversion | $34.2B / $9.2B | NTM conversion +7.5% | STRUCTURAL POSITIVE |
| Adjusted EBITDA | $994M | +9.2%; margin ~22.8% | STRUCTURAL POSITIVE |
| Adjusted EPS | $3.15 | +12.1%; above $2.72 snapshot | STRUCTURAL POSITIVE |
| FCF | $360M | +23.3% | STRUCTURAL POSITIVE |
The CRO engine is signed net new business × cancellation rate × backlog conversion − reimbursed pass-through and labor. A 1.22x book-to-bill and 7.5% growth in expected next-12-month backlog conversion are better leading indicators than current GAAP EPS. Commercial Solutions also accelerated through patient solutions, engagement services, analytics, consulting, and AI adoption. The compound positive is bookings, backlog conversion, and cash flow all improving simultaneously.
The main quality constraint is leverage and adjustments. Net debt was $14.09 billion, or 3.59x LTM adjusted EBITDA; EV/EBITDA is therefore the primary lens. At roughly 167 million diluted shares and the $243.08 close, equity value is about $40.6 billion and EV about $54.7 billion. Against the $4.00–$4.05 billion FY EBITDA guide, that is roughly 13.6x. Interest and leverage sensitivity matter more than the headline P/E. Organic deleveraging occurs if EBITDA grows high single digits and FCF is not consumed by buybacks/acquisitions, but Q2 included $398 million of repurchases.
FY revenue guide rose to $17.275–$17.475 billion; EBITDA to $4.00–$4.05 billion; adjusted EPS to $12.80–$13.00. The revenue midpoint increase reflects ~100 bps better organic growth and 50 bps more M&A, offset by ~80 bps worse FX. FY2 should track backlog conversion plus Commercial Solutions growth, but debt and acquisition appetite determine equity conversion. A one-turn EV/EBITDA move is worth roughly $4.0 billion, or ~$24/share; valuation risk is material after the rally.
Provisional thesis matrix: demand/bookings improved; backlog conversion improved; margin reinforced; leverage unchanged; capital allocation mixed; guide improved; credibility pending call. Business and estimate deltas are positive; stock delta is strongly positive and absorbs about one valuation turn.
Subsector and competitive prior. Clinical-research organizations sit between biopharma sponsors, investigators, regulators, patients, laboratories, and data systems. Revenue is created when signed awards convert through site activation, patient recruitment, monitoring, data management, and regulatory milestones. Book-to-bill captures new awards, backlog captures contracted work, and next-12-month conversion measures how quickly that backlog becomes revenue. Cancellations, scope changes, reimbursed expenses, and labor utilization can make any one measure misleading. IQVIA is differentiated by combining a global CRO with healthcare data, analytics, commercialization services, and technology; the combined platform can improve trial design and recruitment while selling into the same sponsor base.
The Q2 signal is unusually coherent: net new bookings grew, book-to-bill exceeded one, expected conversion accelerated, EBITDA grew slightly faster than revenue, and free cash flow improved. That alignment reduces the chance that revenue strength is merely reimbursed pass-through or acquisition accounting. The remaining debate is durability. Large awards can be lumpy, biotech funding can change sponsor behavior, and Commercial Solutions growth can mix organic demand with acquisitions and AI-branded services. Complete Q&A is necessary to test cancellation trends, funding cohorts, pricing, and the organic contribution of AI tools.
Leverage and equity bridge. The enterprise value framework matters because $14.09 billion of net debt absorbs a significant portion of business value. EBITDA growth and free cash flow delever the equity mechanically; repurchases at a high share price can slow that process. A base case should use the $4.00–$4.05 billion EBITDA guide, separate reimbursed revenue from service growth, and model interest expense against the actual debt schedule. FY2 upside requires book-to-bill above roughly 1.1x, mid-to-high-single-digit conversion growth, stable cancellations, and leverage moving below 3.5x. A one-turn EV/EBITDA re-rating moves equity by about $24 per share, so multiple risk can overwhelm a modest EPS beat.
The $220 entry level retains the operational improvement while removing roughly one valuation turn from the post-print price. The bull case is a synchronized CRO and commercialization recovery with data/AI cross-sell; the bear case is that bookings normalize, acquisition contribution masks organic growth, and buybacks delay deleveraging. The release strengthens the business case and raises FY1, but the 14% stock gain immediately capitalizes much of it. Without Q&A on cancellations and capital allocation, the correct action is to hold the evidence, not chase the reaction.
Three decisive call questions: Are cancellations and change orders improving with bookings? What portion of Commercial Solutions growth is organic AI adoption versus M&A? Will FCF prioritize deleveraging below 3x or continued buybacks?
Decision card. HOLD; wait ≤$220; medium confidence. Confirm with book-to-bill ≥1.15x, NTM backlog conversion ≥7%, and net leverage ≤3.5x. Falsify with book-to-bill <1.0x, conversion growth <4%, or leverage >3.8x. Full current/prior Q&A and sentiment remain PENDING — CALL, due 2026-07-29 08:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. TransUnion delivered 15% reported and 10% organic constant-currency growth, adjusted EPS of $1.23, and raised FY guidance. U.S. Financial Services grew 18%, but Consumer Interactive fell 3% and adjusted EBITDA margin declined 90 basis points. The stock closed $83.84, +8.5%. Action: HOLD; wait ≤$78.
| KPI | Q2 | Rate of change / mechanism | Classification |
|---|---|---|---|
| Revenue | $1.310B | +15%; +10% organic CC | STRUCTURAL POSITIVE |
| U.S. Financial Services | $496M | +18% | STRUCTURAL POSITIVE |
| Emerging Verticals | $354M | +9% | STRUCTURAL POSITIVE |
| Consumer Interactive | $142M | -3% | STRUCTURAL NEGATIVE |
| Adjusted EBITDA / margin | $456M / 34.8% | +12%; margin -90 bps | MIXED |
| Adjusted EPS | $1.23 | +14%; above $0.99 snapshot | STRUCTURAL POSITIVE |
| FY adjusted EPS guide | $4.75–$4.83 | raised | STRUCTURAL POSITIVE |
The engine is credit/fraud/marketing query volume × price and product mix − data/technology cost. Financial Services growth indicates lenders and mortgage participants are buying more data and risk tools; Emerging Verticals broadens the engine. International organic growth was 6%, led by Canada, the UK, and India. Consumer Interactive is the offset and may reflect weaker direct-to-consumer subscription/monitoring demand.
Headline reported growth overstates underlying expansion by about five points because acquisitions contribute roughly four points and FICO mortgage royalties roughly three points to FY26, with overlap in the bridge. Management explicitly guides FY organic constant-currency growth to 8%–9%. The buried signal is margin: 10% organic growth produced only 7% organic adjusted-EBITDA growth, so incremental margin is currently negative. Integration, product investment, and mix must reverse for FY2 EPS to compound.
The balance sheet carries ~$5.6 billion debt and $0.84 billion cash. Against FY adjusted EBITDA midpoint ~$1.817 billion, net leverage is roughly 2.6x, below the 3x trigger but still relevant. At $83.84 and FY EPS midpoint $4.79, P/E is ~17.5x. That is reasonable if organic growth stays high single digits and margin returns above 35%; it is not a bargain after the rally.
Provisional thesis matrix: demand improved; product breadth improved; organic growth reinforced; margin weakened; capital allocation mixed after ~$150 million YTD repurchases; guide improved; credibility pending call. Business and estimate deltas positive; stock delta positive and mostly justified.
Subsector and competitive prior. Credit bureaus and information-services platforms monetize data coverage, identity resolution, scoring and fraud tools, regulatory compliance, and workflow integration. Lenders, insurers, landlords, employers, marketers, and consumers create query volume; proprietary credit files and embedded decisioning make switching costly. The value chain includes data furnishers upstream, the bureau’s matching/analytics layer, and lenders or platforms downstream. Revenue can grow through more credit applications, higher price per query, new fraud/marketing products, acquisitions, and royalties. Those sources have different margins and cyclicality, so organic constant-currency revenue and segment EBITDA are more informative than reported growth alone.
U.S. Financial Services is the most cyclical and valuable current signal. Mortgage and credit activity can generate bureau queries, while FICO-related royalties may inflate revenue without comparable proprietary economics. Emerging Verticals diversifies the volume base; International adds secular formalization and credit penetration but introduces currency and regional execution; Consumer Interactive is a direct subscription/partner channel with different acquisition costs. The quarter shows broad demand but a weak conversion: 10% organic revenue growth versus 7% organic EBITDA growth. That negative incremental margin could reflect royalties, integration, investment, or mix; the release cannot distinguish them.
Estimate and balance-sheet bridge. FY1 uses adjusted EPS of $4.75–$4.83 and EBITDA near $1.817 billion, with organic constant-currency growth of 8%–9%. FY2 needs high-single-digit organic growth to translate into margin above 35%, while integration spending and royalty mix normalize. Net leverage around 2.6x is manageable, but continued repurchases compete with debt reduction and reduce the margin for error if credit volumes slow. A 100-basis-point EBITDA-margin shortfall on roughly $5 billion of revenue would remove about $50 million of EBITDA before financing effects.
At 17.5x the FY1 midpoint, valuation is not excessive if the company restores operating leverage. The $78 threshold gives a lower multiple and a buffer against a royalty or integration-driven margin miss. The bull case is that credit demand, fraud tools, and international penetration compound while acquired assets cross-sell through the platform. The bear case is that headline growth is acquisition/royalty heavy, Consumer Interactive continues to decline, and margin fails to scale. The release answers the demand question positively but leaves the economics of that demand unresolved. Full Q&A must isolate FICO royalties, core credit volume, integration cost, and exit-rate margin before the guide raise becomes a clean FY2 thesis.
Three decisive call questions: Why did EBITDA grow slower than organic revenue? How much Financial Services growth is mortgage/FICO royalty versus core credit volumes? What is the exit margin after Mexico/RealNetworks integration?
Decision card. HOLD; wait ≤$78; medium confidence. Confirm with organic CC growth ≥8%, adjusted margin ≥35%, and Consumer Interactive stabilized. Falsify with organic growth <6%, margin <34%, or net leverage >3x. Full current/prior Q&A and sentiment remain PENDING — CALL, due 2026-07-29 08:00 ET.
These are explicit deferments, not completed analysis. They receive no fresh BUY/SELL verdict. Catch-up deadline is 2026-07-29 08:00 ET unless a later issuer event is specified.
| Ticker | Known target-date fact | Exact blocked input | Required question |
|---|---|---|---|
| KO | Result detected; close +4.8% | Current issuer Q2 release was not indexed in the validated primary-source set; full Q&A/prior comparison | Was volume acceleration broad and did fairlife disruption affect mix or margins? |
| SPGI | Result detected; close -4.7% | Primary release, ratings issuance/indices/market-intelligence KPI bridge, full Q&A | Did recurring data growth offset issuance cyclicality and AI investment? |
| GSK | Result/call flag only | Issuer release, product/FX consensus bridge, full Q&A | Which franchises changed FY26/FY27 estimates? |
| BCS | Result detected; close -5.2% | Official half-year package, NII/IB/credit expectations, full Q&A | Did NII or capital return miss the valuation-implied bar? |
| ITW | Result detected | Issuer segment organic-growth/margin release and full Q&A | Is enterprise initiative margin still offsetting end-market volume? |
| AMT | Result detected | AFFO, churn, tenant capex, FX and leverage bridge; full Q&A | Is U.S. organic tenant billings accelerating? |
| ECL | Result detected | Organic sales/price-volume/margin primary tables and full Q&A | Is volume now carrying growth as pricing normalizes? |
| HLT | Result detected | RevPAR, net-unit growth, fee and pipeline bridge; full Q&A | Does system growth offset softer U.S. RevPAR? |
| PCAR | Result detected | Deliveries, backlog, parts margin and full Q&A | Is truck-cycle weakness already through earnings? |
| PYPL | Result detected | TPV, branded checkout, transaction margin dollars and full Q&A | Is branded checkout accelerating without take-rate dilution? |
| FMX | Result detected | Mexico retail/bottling primary package and full Q&A | Are OXXO traffic and margin recovering together? |
| CNC | Official headline release available | Complete HBR bridge, one-time Medicare/Commercial contribution, full Q&A | Is the $0.50 non-recurring guide benefit masking the medical-cost run rate? |
| DTE | Result detected | Utility EPS/weather/rate-base bridge and full Q&A | Is load growth converting without regulatory lag? |
| CNP | Result detected | Weather-normalized load, O&M and regulatory package | Does Houston load growth clear the capex/financing hurdle? |
| XYL | Result detected | Organic orders, backlog, segment margin and full Q&A | Is water-infrastructure backlog converting at higher incremental margin? |
| HUBB | Result detected | Organic sales/orders and grid/data-center mix; full Q&A | Is utility demand offsetting industrial normalization? |
| PHG | Result detected | Comparable order intake, diagnosis/treatment margin, remediation cash | Is order growth finally translating after China weakness? |
| INCY | Result detected; close +10.9% | Official issuer Q2 package not accessible in validated set; one-time Opzelura CMS settlement bridge; full Q&A | How much of EPS/revenue is recurring after the CMS agreement? |
| CMS | Result detected | Weather/rate-base and financing bridge | Does EPS quality depend on weather or structural rate-base growth? |
| TXT | Result detected; close -5.7% | Aviation backlog/delivery, Bell/Systems margin and full Q&A | Did Aviation orders or pricing weaken structurally? |
| DINO | Result detected | Refining throughput/margin/turnaround and cash-return bridge | Is the beat crack-spread beta or structural reliability? |
| IVZ | Result detected | AUM flows, fee rate, performance fees and full Q&A | Are organic flows improving ex market beta? |
| PNR | Actual release not validated | Current issuer release and pool/water KPI package | Is residential normalization offset by commercial water growth? |
| OSK | Actual release not validated | Backlog, access-equipment orders and defense margin | Is access-cycle weakness spreading into backlog? |
| ALKS | Actual release not validated | Product revenue/pipeline milestones and full Q&A | Does commercial growth fund the pipeline without margin slippage? |
| RGEN | Actual release not validated; price move material | Bioprocess orders, book-to-bill and guidance | Is destocking ending with real order growth? |
| AXTA | Actual release not validated; price move material | Refinish/industrial volume-price and margin bridge | Is coating demand improving or only price/cost? |
| AWI | Actual release not validated | Mineral fiber volume/price and project backlog | Is commercial construction volume stabilizing? |
| PJT | Actual release not validated | Advisory backlog/conversion and compensation ratio | Is revenue acceleration durable beyond event timing? |
| CVLT | Actual release not validated | ARR, subscription NRR, billings and margin | Is cyber-resilience demand accelerating recurring revenue? |
| HRI | Actual release not validated | Rental rates, fleet utilization, leverage and guide | Is rental-cycle pricing holding as utilization slows? |
| RITM | Actual release not validated | Book value, MSR marks, origination gain-on-sale, funding | Is earnings cash-based or mark-driven? |
| KNSA | Actual release not validated | ARCALYST demand and pipeline cash-burn bridge | Does commercial leverage offset pipeline risk? |
| FELE | Actual release not validated | Water/fuel systems volume-price and margin | Is infrastructure demand broad or project-timed? |
| PII | Actual release not validated | Dealer inventory, retail sell-through and promotions | Has powersports channel destocking ended? |
| ABG | Actual release not validated | New/used unit, F&I, parts/service and floorplan | Is auto affordability compressing unit economics? |
| ITRI | Actual release not validated | backlog, bookings, gross margin and guide | Is grid modernization converting despite revenue timing? |
| CURB | Actual release not validated | FFO, leasing spreads, occupancy and balance sheet | Are convenience-retail centers compounding NOI? |
| AB | Actual release not validated | AUM flows, fee rate and performance fees | Are active flows positive ex market beta? |
| CBU | Actual release not validated | NIM, deposits and credit bridge | Is funding beta stabilizing without credit deterioration? |
| JBLU | Actual release not validated | TRASM/CASM ex fuel, liquidity and capacity plan | Is the turnaround reducing cash burn before balance-sheet risk rises? |
The 2026-07-27 PM report left 25 Tier 3 names due for 2026-07-28 AM catch-up. The AM collector did not include those AMC issuers, and no deterministic carry-forward bundle was produced. Their status is therefore ROLLED — EXACT SOURCE PACKAGE ABSENT, not silently closed:
| Tickers | Rolled status | Exact blocked inputs | New deadline |
|---|---|---|---|
| CINF, PFG, BRO, SUI, UDR, TFII, SANM, RMBS, TIMB, BRX, UHS, ESI, SSD, APLD, NE, KRC, CDP, AGYS, NBTB, HTO, NVTS, NTB, NWBI, BLX, HAPN | TIER 3 — DEFERRED | Issuer release, dated consensus/hurdle, complete current Q&A, and prior-call comparison; none were present in the AM evidence JSON | 2026-07-29 08:00 ET |
No final call, sentiment score, or thesis verdict is issued for these names.
| Ticker | Status | Unresolved evidence | Required source / deadline |
|---|---|---|---|
| BA | PENDING_TRANSCRIPT | 737 rate quality, FCF timing, BDS loss exposure | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| UPS | PENDING_TRANSCRIPT | Volume, revenue-per-piece mix, network savings, International margin | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| RCL | PENDING_TRANSCRIPT | Expense timing, itinerary pressure, capex ROIC | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| SHW | PENDING_TRANSCRIPT | Price/volume split, raw-material recovery, Suvinil contribution | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| CARR | PENDING_TRANSCRIPT | Data-center margin, delivery timing, FY guide bridge | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| IQV | PENDING_TRANSCRIPT | Cancellations, AI organic growth, deleveraging | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| TRU | PENDING_TRANSCRIPT | Margin dilution, FICO royalties, integration exit rate | Complete current/prior Q&A by 2026-07-29 08:00 ET |
| GLW | SCORED | FY27 photonics and LTA economics remain unmodelable, but call gate passed | Next quarterly disclosure |
| Ticker | Tier | Status | Analytical words | Causal KPIs | Q&A count | Sourced debate claims | Prior-call deltas | Omissions | FY1/FY2 bridge | Transcript provenance | Sentiment | Tone delta | Answer quality | Pressure delta | Tracker read-back | Failed/deferred gates |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLW | 1 | FINAL — POST CALL | 1,379 | 7 | 6 | 4 | 3 | 2 | Complete / sensitivity | Full current Investing.com + full prior MarketBeat | SCORED | 0 | 62 | -25 | PASS | None |
| BA | 1 | PROVISIONAL — RELEASE ONLY | 863 | 7 | 0 | 3 | 0 | 3 | Driver bridge | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| UPS | 1 | PROVISIONAL — RELEASE ONLY | 865 | 7 | 0 | 3 | 0 | 3 | FY1 + FY2 sensitivity | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| RCL | 1 | PROVISIONAL — RELEASE ONLY | 783 | 7 | 0 | 3 | 0 | 3 | FY1 + FY2 sensitivity | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| SHW | 1 | PROVISIONAL — RELEASE ONLY | 806 | 7 | 0 | 3 | 0 | 3 | FY1 + FY2 sensitivity | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| CARR | 1 | PROVISIONAL — RELEASE ONLY | 737 | 7 | 0 | 3 | 0 | 3 | FY1 + FY2 sensitivity | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| IQV | 1 | PROVISIONAL — RELEASE ONLY | 774 | 7 | 0 | 3 | 0 | 3 | FY1 + FY2 sensitivity | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| TRU | 1 | PROVISIONAL — RELEASE ONLY | 740 | 7 | 0 | 3 | 0 | 3 | FY1 + FY2 sensitivity | Full current/prior Q&A not verified | PENDING_TRANSCRIPT | n/a | n/a | n/a | PASS | Call-only gates |
| KO, SPGI, GSK, BCS, ITW, AMT, ECL, HLT, PCAR, PYPL, FMX, CNC, DTE, CNP, XYL, HUBB, PHG, INCY, CMS, TXT, DINO, IVZ | 3 | DEFERRED | Ledger row | 0 | 0 | 1 | 0 | 1 | Not complete | Not verified | DEFERRED | n/a | n/a | n/a | PASS | Primary/expectations/call gates |
| PNR, OSK, ALKS, RGEN, AXTA, AWI, PJT, CVLT, HRI, RITM, KNSA, FELE, PII, ABG, ITRI, CURB, AB, CBU, JBLU | 3 | DEFERRED | Ledger row | 0 | 0 | 1 | 0 | 1 | Not complete | Not verified | DEFERRED | n/a | n/a | n/a | PASS | Current result not validated |
| 25 prior AMC names listed above | 3 | ROLLED / DEFERRED | Ledger row | 0 | 0 | 1 | 0 | 1 | Not complete | AM carry-forward bundle absent | DEFERRED | n/a | n/a | n/a | Not rerendered | Exact issuer/consensus/call package absent |
/Users/max/morningsignal-research/state/earnings/earnings_context_2026-07-28_AM.json, generated 2026-07-28 15:39 ET. Use limited to calendar discovery, market-cap triage, and the dated EPS-consensus snapshot; stale/mismatched actual-revenue fields were rejected.